Showing results (21-30 of 92) with videos related to

Sort By:
Pageof 10
Cancers|November 5, 2020
The Effect of Beta-Adrenergic Blocking Agents in Cutaneous Melanoma-A Nation-Wide Swedish Population-Based Retrospective Register StudyDimitrios Katsarelias, Hanna Eriksson, Rasmus Mikiver, et al.
Lakartidningen|May 2, 2025
[Cell therapy with tumor infiltrating lymphocytes; a therapeutic alternative for malignant melanoma and soon also other types of cancer]Stina L Wickström, Jonas A Nilsson, Andreas Lundqvist, et al.
Cancers|June 24, 2022
A Fraction of CD8+ T Cells from Colorectal Liver Metastases Preferentially Repopulate Autologous Patient-Derived Xenograft Tumors as Tissue-Resident Memory T CellsFrank Liang, Lisa M Nilsson, Fabian Byvald, et al.
Science Translational Medicine|January 31, 2014
Antioxidants accelerate lung cancer progression in miceVolkan I Sayin, Mohamed X Ibrahim, Erik Larsson, et al.
Cancers|January 5, 2021
Reply to Comment on Katsarelias, D., et al. "The Effect of Beta-Adrenergic Blocking Agents in Cutaneous Melanoma-A Nation-Wide Swedish Population-Based Retrospective Register Study." Cancers 2020, 12, 3228Dimitrios Katsarelias, Hanna Eriksson, Rasmus Mikiver, et al.
Cancers|September 10, 2021
The Microenvironment of Small Intestinal Neuroendocrine Tumours Contains Lymphocytes Capable of Recognition and Activation after ExpansionTobias Hofving, Frank Liang, Joakim Karlsson, et al.
BMC Cancer|July 6, 2010
Myc suppression of Nfkb2 accelerates lymphomagenesisUlrich Keller, Jürgen Huber, Jonas A Nilsson, et al.
Molecular and Cellular Biology|January 30, 2004
Mnt loss triggers Myc transcription targets, proliferation, apoptosis, and transformationJonas A Nilsson, Kirsteen H Maclean, Ulrich B Keller, et al.
Oral Oncology|March 17, 2024
MYB alternative promoter activity is increased in adenoid cystic carcinoma metastases and is associated with a specific gene expression signatureJunchi Huang, André Fehr, Fredrik Jäwert, et al.
Melanoma Research|November 10, 2021
Epigenetic therapy to enhance therapeutic effects of PD-1 inhibition in therapy-resistant melanomaVasu R Sah, Joakim Karlsson, Henrik Jespersen, et al.
Pageof 10